drugset / Trial / NCT02080403

The Efficacy and Safety of Chlorhexidine Gluconate Chip (PerioChip®) in Therapy of Peri-implantitis

NCT02080403

Phase 3 Completed 290 enrolled Dexcel Pharma Technologies Ltd.
RandomizedParallel-groupSingle-blindTreatment

Summary

The objective of the study is to assess the efficacy and safety of PerioChip® (Chlorhexidine gluconate chip) in the treatment of patients with Peri-implantitis. The hypothesis of the study is that PerioChip® in adjunct to mechanical subgingival debridement is more effective in the treatment of peri-implantitis when compared to the common method of mechanical subgingival debridement alone. The primary efficacy measure will be the reduction in probing pocket depth at 6 months as measured at sites of qualifying target implant.

Timeline

Start
2014-07
Primary completion
2018-10
Completion
2018-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Chlorhexidine gluconate Other / unclassified 2.5 mg Other

Indications